-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Drug research and development can be said to be the history of the struggle between human beings and diseases, and a certain effective substance has been discovered intentionally or unintentionally in history, which has been accumulated in the medical experience book, thus becoming the source
of people's good wishes for the treatment of various diseases.
With the development of human history, diseases are also constantly playing with human beings, blocking the way on the road to human longevity and health, and in the face of the mutation and transformation of diseases, drugs that can be prescribed are often not readily available
.
Social progress, scientific and technological development has promoted human cognition of diseases, so that human beings have the confidence to overcome the "roadblock", drug research and development has entered a period of vigorous development, its modernization, standardization development requirements have also made relevant policies and systems emerge, the research and development process has been repeatedly standardized while ensuring that new drugs are safer and more effective
.
Drug R&D and marketing should go through research and design, preclinical safety and efficacy research, drug preparations, clinical trials, technology transfer, declaration and production registration, listing and continuous monitoring, and the purpose of R&D is to design a high-quality, sustainable production of products that meet its expected quality standards
.
This is not only a complex project, it has the characteristics of
high risk, high investment and long cycle time from the beginning.
Taking the traditional sense of small molecule compounds, the research and development process includes:
Taking the traditional sense of small molecule compounds, the research and development process includes:Discovery and development of laboratory targets, preclinical research (including clinical studies, phase I, phase II, phase III clinical trials), new drug applications, marketing approvals and phase IV clinical studies
.
Generally, it takes several years for new drugs to come out of the laboratory to be applied, and it is reported that nearly ninety percent of drugs will be eliminated in the phase I clinical stage, which shows the long time and low efficiency of traditional new drug research and development methods
.
Due to the duality of drug treatment, it will show new adverse reactions after marketing, which will affect its clinical application, market response, support from relevant aspects, and doctor-patient attitude
towards drug research and development.
All links affect the hearts of researchers, thereby restricting the improvement and investment of new drugs, and making innovation accumulate day after day, which is exciting!
After the outbreak of COVID-19, the number of infections worldwide is still increasing, the medical situation is grim, and some progress has been made in the development of innovative drugs and the development of new indications for the treatment of new coronavirus drugs under emergency conditions at the beginning of the epidemic, but no specific drugs
have been found.
With more in-depth research, China and abroad have accumulated a lot of experience in the research and development of drugs for the treatment of COVID-19, but what is more expected is that specific drugs can complete the research and pass the approval of the drug administration department as soon as possible!
In the past, according to data reports, hundreds of new drugs came out every year in the world, economic development promoted enterprises to increase investment in new drug research and development, various new targets, new treatment methods continue to be discovered and applied, people's health is more secure - and from now on in the face of the epidemic rampant emergency situation, new drug clinical development needs to be improved
.
In the next few years, generic drugs will still be the main body of the world's medical and health needs, and it is beneficial
for patients with common diseases to obtain treatment drugs at low prices.
For a virus like the new coronavirus, due to its structural characteristics and mutation characteristics, there are natural difficulties in the development of antiviral drugs, but it has a great impact on human survival, and the need for "innovation" to speed up the results is more urgent
.
Most countries have taken innovative drugs as the focus of drug research and development, and have introduced incentive policies in the application of advanced technology in pharmaceutical research, intelligent equipment research and development, drug registration review and other aspects, which can consider the source to empower industry innovation and production innovation, which may be more beneficial
to reduce drug costs and meet patient needs faster.
Looking forward to the guidance of drug administration and the assistance of all parties, more cutting-edge technologies will be put into use in drug research and development, intelligently simplify complex data screening, replace people who cannot do and do not want to operate, eliminate the inherent difficulties in traditional research and development, and shorten the time
of innovative drug research and development.
Looking forward to "tomorrow", no matter how severe the epidemic is, it will also be defeated by the hands of mediciners, so that society will no longer talk about the "crown" color change, and let people live
freely and happily.
As a medical person, I sincerely hope that with the joint efforts of pharmaceutical research and development, pharmaceutical machines, pharmaceutical companies, etc.
, new technologies will be repeatedly produced, and new diseases will respond quickly to new diseases, so that innovative drugs can appear like "mushrooms after rain", and the treatment effect will be immediate, and at the same time, it will have a deeper understanding of the past and present life of the epidemic, and make early preparations for the prevention of unoccurring diseases!
